Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
18p Deletion Syndrome
15%
Aberrations
27%
Anti-amyloidogenic
15%
APP Mice
15%
B-cell Lymphoma 2 (Bcl-2)
15%
Brain Uptake
15%
Cell Adhesion
15%
CRISPR/Cas9 Genome Editing
15%
Cyclin-dependent Kinase 4 (CDK4)
30%
D4Z4
55%
D4Z4 Repeats
29%
Derepression
20%
DNA Damage Response
15%
DNA Methyltransferase 3B (DNMT3B)
22%
DUX4
42%
Dysferlin
15%
Epigenetic Repression
17%
Exon Deletion
21%
Facioscapulohumeral muscular Dystrophy
78%
FSHD1
21%
FSHD2
44%
Fusion Protein
17%
Gene Expression Pattern
15%
Hemizygous
15%
Hinge Domain
15%
Human Monocytes
15%
Hypomethylation
17%
ICF Syndrome
19%
Isogenic
16%
Loss Amplification
15%
Loss Function
17%
Muscle Differentiation
15%
Mutation Spectrum
17%
Mutational Spectrum
15%
Myeloid Cell leukemia-1 (Mcl-1)
15%
Neuroblastoma
100%
Patient Characteristics
15%
Pediatric Malignancy
16%
Penetrance
15%
Protein Level
16%
Residential Time
15%
Single-domain Antibody
15%
SMCHD1
59%
Structural Maintenance of Chromosomes
15%
Synergistic Effect
17%
Synergistic Response
16%
Therapeutic Target
30%
Therapeutic Vulnerabilities
18%
Tumor Characteristics
15%
VHH-Fc
15%
Biochemistry, Genetics and Molecular Biology
Alpha Thalassemia/Mental Retardation X-Linked
30%
Amyloid Protein
15%
Autosomal Recessive Disorder
5%
Biodistribution
7%
Blood Brain Barrier
15%
Chimeric Protein
16%
Chromosomal Aberration
5%
Chromosome 11q
15%
Chromosome 18
5%
Chromosome 4
13%
Clinical Trial
15%
CRISPR/Cas9
19%
Derepression
31%
DNA Methyltransferase
15%
DNA Repair
5%
DNMT3B
15%
DUX4
60%
Enzyme Active Site
5%
Epigenetic Repression
17%
Epigenetics
8%
Exon
17%
Gender Bias
15%
Gene Expression
15%
Genetics
20%
Genome Editing
17%
Guanine
15%
Hemizygosity
15%
High Throughput Screening
5%
Intron
11%
Kinase
15%
Loss of Function Mutation
5%
Methylation
20%
Missense
23%
Missense Mutation
5%
MUTYH
15%
Myogenesis
15%
N-Terminus
7%
P14arf
6%
P53
15%
Penetrance
30%
Pharmacokinetics
7%
Phosphotransferase
15%
Plasma Half Life
11%
Preclinical Study
5%
Repressor
12%
Single-Domain Antibody
15%
Skeletal Muscle
7%
Somatic Cell
10%
Transcription Factors
5%
Wild Type
10%
Medicine and Dentistry
Biogenesis
7%
Biological Marker
16%
Cancer
15%
Cell Line
8%
Cell Mutant
6%
Checkpoint Kinase 1
15%
Childhood Cancer
9%
Chromosome 11q
15%
Clinical Trial
9%
Disease
6%
DNA Damage Response
15%
DNA Repair
6%
Ewing Sarcoma
6%
Exon
15%
Facioscapulohumeral Muscular Dystrophy
15%
Ganglioglioma
7%
Ganglioneuroblastoma
71%
Gene Expression
15%
Homologous Recombination
6%
Intracranial Tumor
15%
Irinotecan
15%
Lethality
15%
Medulloblastoma
10%
Neoplasm
19%
Olaparib
12%
Osteosarcoma
6%
PARP Inhibitor
6%
Pediatric Cancer
10%
Pediatrics
30%
Poly ADP Ribose Polymerase
15%
Recombination Repair
6%
Rhabdomyosarcoma
10%
Solid Malignant Neoplasm
21%
Therapeutic Target
15%
Tumor
11%
Xenograft
6%
